Work

Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin’s lymphoma

Year: 2016

Type: article

Abstract: To the Editor,Programmed death-1 (PD-1) checkpoint inhibitors have shown promising results for the treatment of various tumor types, including relapsed and refractory Hodgkin’s lymphoma (HL) [1,2]....

Source: Acta Oncologica

DOI: 10.3109/0284186x.2015.1125017

Authors: Joycelyn J. X. Lee, Alexandre Chan, Tiffany Tang

Institutions: National Cancer Centre Singapore, National University of Singapore

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W2300884763

FWCI: 4.109

Cites: 7

Cited by: 70

Related to: 10